Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 9/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.31 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2523197 | 0.90 | CYP1A2 (0.39) | CYP1A2CYP2C9CYP2C19MAPTHTT | |
| SCHEMBL24439665 | 0.81 | SMN1; SMN2 (0.35) | CYP1A2CYP2C9CYP2C19MAPTHTT | |
| SCHEMBL24439546 | 0.77 | SMN1; SMN2 (0.35) | CYP1A2CYP2C9CYP2C19MAPTHTT | |
| SCHEMBL30320387 | 0.73 | CYP11B2 (0.36) | LMNA | |
| SCHEMBL25274344 | 0.71 | CCNT1 (0.32) | — | |
| SCHEMBL24439448 | 0.71 | SMN1; SMN2 (0.37) | CYP1A2CYP2C19MAPTHTTALDH1A1 | |
| SCHEMBL8795481 | 0.71 | ALDH1A1 (0.35) | CYP1A2CYP2C9CYP2C19MAPTALDH1A1 | |
| SCHEMBL17869465 | 0.70 | CHRNB2 (0.31) | — | |
| SCHEMBL27199355 | 0.70 | CYP1A2 (0.39) | CYP1A2CYP2C9CYP2C19MAPTHTT | |
| SCHEMBL9869341 | 0.69 | POLB (0.38) | ALDH1A1POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0562061-B1 | HAIR-DYEING AGENT CONTAINING AMINOPYRAZOLE DERIVATIVES, AND NEW PYRAZOLE DERIVATIVES | WELLA AG (DE) | 1997-01-22 | — | — | EP | claimed |
| US-5380340-A | Hair dye containing aminopyrazole derivatives as well as pyrazole derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 1995-01-10 | — | — | US | claimed |
| US-20250143992-A1 | VAT PLUS OXIDATIVE COLORS | WELLA GERMANY GMBH (DE) | 2025-05-08 | — | — | US | disclosed |
| EP-4475959-A1 | HAIR COLORING USING OXIDATIVE DYE PRECURSORS COMPRISING PYRAZOLE PRIMARIES AND COUPLERS, IN COMBINATION WITH SOLUBILIZED VAT DYES, FOR IMPROVING COLOR WASH FASTNESS | Wella Germany GmbH (DE) | 2024-12-18 | — | — | EP | disclosed |
| WO-2023152322-A1 | HAIR COLORING USING OXIDATIVE DYE PRECURSORS COMPRISING PYRAZOLE PRIMARIES AND COUPLERS, IN COMBINATION WITH SOLUBILIZED VAT DYES, FOR IMPROVING COLOR WASH FASTNESS | WELLA GERMANY GMBH (DE) | 2023-08-17 | — | — | WO | disclosed |
| EP-1556389-B9 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2015-09-09 | — | — | EP | disclosed |
| EP-1556389-B3 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2015-04-01 | — | — | EP | disclosed |
| US-20090012054-A1 | Cephem Compounds and Use as Antimicrobial Agents | ASTELLAS PHARMA INC. (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1994035-A1 | CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007119511-A1 | CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS | ASTELLAS PHARMA INC. (JP) | 2007-10-25 | — | — | WO | disclosed |
| EP-1556389-B1 | CEPHEM COMPOUNDS | ASTELLAS PHARMA INC (JP) | 2007-07-25 | — | — | EP | disclosed |
| US-20070037786-A1 | Cephem compounds | WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-7129232-B2 | For therapy of of infectious diseases | ASTELLAS PHARMA INC. (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20040132994-A1 | Cephem compounds | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2004-07-08 | — | — | US | disclosed |
| EP-0562061-B1 | HAIR-DYEING AGENT CONTAINING AMINOPYRAZOLE DERIVATIVES, AND NEW PYRAZOLE DERIVATIVES | WELLA AG (DE) | 1997-01-22 | — | — | EP | disclosed |
| US-5380340-A | Hair dye containing aminopyrazole derivatives as well as pyrazole derivatives | WELLA AKTIENGESELLSCHAFT (DE) | 1995-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037786-A1 | Cephem compounds | CEP170, ABCB11, SLC7A1 | CYP1A2 315/4885CYP2C9 92/4885CYP2C19 103/4885 |
| US-20040132994-A1 | Cephem compounds | CEP170, ABCB11, RCC2 | CYP1A2 443/4885CYP2C9 116/4885CYP2C19 189/4885 |
| US-20250143992-A1 | VAT PLUS OXIDATIVE COLORS | VAT1, POR, GSR | CYP1A2 152/4885CYP2C9 169/4885CYP2C19 408/4885 |
| US-20090012054-A1 | Cephem Compounds and Use as Antimicrobial Agents | CEP170, Q6ZSR9, H1-10 | CYP1A2 1846/4885CYP2C9 573/4885CYP2C19 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.